Kindly MD, Inc. (KDLY) AI Stock Analysis

• Market Cap: N/A
• Dividend Yield: N/A
• Average Volume (3M): 1.19M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.99
• Revenue Growth: -27.83%
• EPS Growth: -123.51%
• Country: US
• Employees: 23
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Equipment & Services
• EPS (TTM): -0.60
• Shares Outstanding: 6,029,648
• 10 Day Avg. Volume: 153,060
• 30 Day Avg. Volume: 1,189,975
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 3.14
• Price to Cash Flow (P/CF): -2.20
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Kindly MD, Inc. receives a low score due to significant financial challenges, including declining revenues and profitability issues. While the technical indicators show a neutral to slightly bearish sentiment, the valuation is unattractive due to negative earnings. The company's financial health and strategic initiatives need substantial improvement for sustainable growth.

Kindly MD, Inc. Business Overview & Revenue Model

Company Description

Kindly MD, Inc. (KDLY) is a healthcare company operating within the telemedicine sector. The company focuses on providing remote medical consultations and health services through a user-friendly digital platform. Kindly MD aims to enhance accessibility to healthcare by connecting patients with qualified medical professionals for various non-emergency medical needs.

How the Company Makes Money

Kindly MD, Inc. makes money through a subscription-based model and pay-per-visit fees for telemedicine consultations. The company generates revenue by charging patients for virtual doctor visits, which can be accessed through their online platform. Additionally, Kindly MD may partner with healthcare providers, insurers, and employers to offer bundled healthcare services, which can include a combination of telehealth consultations, wellness programs, and health management tools. These partnerships help expand their customer base and increase usage of their services, contributing to their overall earnings.

Kindly MD, Inc. Financial Statement Overview

Summary

Kindly MD, Inc. faces significant financial challenges, marked by declining revenues and profitability issues. Despite a moderate debt level, negative equity in 2023 and reliance on financing raise concerns. Cash flow struggles emphasize the need for better operational efficiency and cost management.

Income Statement

Kindly MD, Inc. has faced significant challenges in revenue and profit growth. The Gross Profit Margin remains high at 96.95% for 2024, but the Net Profit Margin is negative at -133.00%, indicating substantial losses. The company has faced revenue decline from the previous year, further exacerbating its profitability issues. The negative EBIT and EBITDA margins highlight operational inefficiencies and the need for cost management.

Balance Sheet

The company's Debt-to-Equity Ratio is 0.31, indicating a moderate level of leverage. However, the negative equity in 2023 raises concerns about financial stability. The Return on Equity is not meaningful due to negative equity in 2023, but the Equity Ratio improved to 69.82% in 2024, reflecting better asset financing through equity.

Cash Flow

Cash flow analysis shows a negative Free Cash Flow of -$3.09 million in 2024, indicating cash management struggles. The Operating Cash Flow to Net Income Ratio is negative, reflecting inefficiencies in converting income into cash. The company heavily relies on financing activities to support its cash needs, which may not be sustainable in the long term.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement		Total Revenue
2.88M	2.72M	3.77M	3.79M	2.50M
	Gross Profit
-5.58K	2.64M	-158.53K	-595.29K	914.92K
	EBIT
-2.63M	-3.35M	-1.62M	-2.69M	61.34K
	EBITDA
-2.28M	-3.35M	-1.36M	-2.42M	66.19K
	Net Income Common Stockholders
-2.94M	-3.62M	-1.62M	-2.54M	149.34K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
186.92K	2.27M	525.50K	186.92K	94.69K
	Total Assets
1.00M	3.68M	1.10M	947.00K	447.64K
	Total Debt
445.40K	783.68K	636.38K	391.13K	109.81K
	Net Debt
258.48K	-1.49M	110.88K	204.21K	15.12K
	Total Liabilities
620.25K	1.11M	1.21M	565.98K	174.56K
	Stockholders Equity
381.01K	2.57M	-108.41K	381.01K	273.09K
Cash Flow		Free Cash Flow
-2.39M	-3.09M	-463.91K	-457.77K	57.84K
	Operating Cash Flow
-2.38M	-3.07M	-449.49K	-140.38K	121.44K
	Investing Cash Flow
-13.29K	-401.63K	-14.42K	-317.39K	-63.60K
	Financing Cash Flow
5.89M	5.22M	802.49K	550.00K	-45.34K

Kindly MD, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1.72
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KDLY, the sentiment is Positive. The current price of 1.72 is above the 20-day moving average (MA) of 1.67, below the 50-day MA of 1.76, and above the 200-day MA of 1.55, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 46.72 is Neutral, neither overbought nor oversold. The STOCH value of 20.47 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KDLY.

Kindly MD, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	54 Neutral	$3.84B	-18.02	-14.99%	6.50%	25.52%	-80.16%
DCTH	51 Neutral	$381.47M	―	-62.43%	―	1701.69%	67.30%
KDLY	45 Neutral		―	-294.13%	―	-27.83%	-123.51%
TDOC	45 Neutral	$1.37B	―	-52.46%	―	-1.26%	-338.56%
AMWL	43 Neutral	$113.17M	―	-54.13%	―	-1.81%	70.88%
OCGN	40 Underperform	$202.51M	―	-154.01%	―	187.79%	32.40%
CARA	29 Underperform	$22.41M	―	-270.01%	―	-65.96%	40.80%